BioLife Solutions, Inc.
NASDAQBioLife Solutions enters its May 7 Q1 2026 earnings call with an unusual split in its data: short sellers have been quietly exiting, yet the stock dropped 12.3% on the week to close at $19.99. The tension between weakening short conviction and a softening price makes this an interesting setup to examine heading into the print. The price action was the headline this week, and most…
Snapshot as of 10 May 2026
BioLife Solutions enters its May 7 Q1 2026 earnings call with an unusual split in its data: short sellers have been quietly exiting, yet the stock dropped 12.3% on the week to close at $19.99. The tension between…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BLFS — free to start on ORTEX.
Sign up for free →Open BLFS on ORTEX